Cas:545354-16-3 3-[5-(hydroxymethyl)pyridin-2-yl]benzonitrile manufacturer & supplier

Chemical Name:3-[5-(hydroxymethyl)pyridin-2-yl]benzonitrile

CAS.NO:545354-16-3

Synonyms:3-[5-(Hydroxymethyl)-2-pyridyl]benzonitrile;2-(2,4-Dichlorophenoxy)-1-(2-methyl-1-piperidyl)-1-propanone

Molecular Formula:C₁₃H₁₀N₂O

Molecular Weight:210.23100

HS Code:2933399090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:56.91000

Exact Mass:210.07900

LogP:2.11258

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3-[5-(Hydroxymethyl)-2-pyridyl]benzonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(2,4-Dichlorophenoxy)-1-(2-methyl-1-piperidyl)-1-propanone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-[5-(Hydroxymethyl)-2-pyridyl]benzonitrile Use and application,3-[5-(Hydroxymethyl)-2-pyridyl]benzonitrile technical grade,usp/ep/jp grade.

Related News: China has asked the European Union for help in buying urgently needed medical supplies from its member countries, the China��s official Xinhua news agency said on Saturday. 3-[5-(hydroxymethyl)pyridin-2-yl]benzonitrile manufacturer Schimpke, an assistant professor in the Division of Minimally Invasive and Bariatric Surgery at Rush Medical College in Chicago, and his colleagues point out that obesity is linked to a considerably higher risk for developing upwards of 40 different serious illnesses, including heart disease and diabetes. 3-[5-(hydroxymethyl)pyridin-2-yl]benzonitrile supplier At present, the additional 300 tons of sunniamine, 300 tons of fluoxamic acid, and 200 tons of cyprodinil have been successfully put into production, and the profitability is good. 3-[5-(hydroxymethyl)pyridin-2-yl]benzonitrile vendor In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being. 3-[5-(hydroxymethyl)pyridin-2-yl]benzonitrile factory At present, the additional 300 tons of sunniamine, 300 tons of fluoxamic acid, and 200 tons of cyprodinil have been successfully put into production, and the profitability is good.